Plasma cell-rich acute rejections in living-related kidney transplantation: A clinicopathological study of 50 cases

Clinical Transplantation

Volumn 29, Issue 9, 2015, Pages 835-841

  Abbas, Khawar ^a   Mubarak, Muhammed ^a   Zafar, Mirza N ^a   Aziz, Tahir ^a   Abbas, Haider ^a   Muzaffar, Rana ^a   Rizvi, Syed A H ^a  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

Author keywords

Acute rejection; Graft outcome; Kidney transplant; Living related; Plasma cell rich infiltrates

Indexed keywords

CD20 ANTIBODY; HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; METHYLPREDNISOLONE; SYNDECAN 1; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE PYELONEPHRITIS; ADULT; ARTICLE; CELL INFILTRATION; CREATININE BLOOD LEVEL; EPSTEIN BARR VIRUS; FEMALE; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIGHT CHAIN; LIVING DONOR; MALE; MONONUCLEAR CELL; PLASMA CELL; PLASMAPHERESIS; POLYOMAVIRUS; PRIORITY JOURNAL; TREATMENT OUTCOME; ADOLESCENT; BIOPSY; CHILD; FOLLOW UP; GRAFT REJECTION; IMMUNOLOGY; KIDNEY; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOPSY; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PLASMA CELLS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84940959518     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12589     Document Type: Article

References (29)

1. Rizvi SA, Naqvi SA, Hussain Z et al. Renal transplantation in developing countries. Kidney Int 2003: 83: S96.
2. Rizvi SA, Naqvi SA, Zafar MN et al. A renal transplantation model for developing countries. Am J Transplant 2011: 11: 2302.
3. Ghoneim MA, Bakr MA, Refaie AF et al. Factors affecting graft survival among patients receiving kidneys from live donors: a single-center experience. Biomed Res Int 2013: 2013: 912413.
4. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 1996: 49: 518.
5. Knight RJ, Burrows L, Bodian C. The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation. Transplantation 2001: 72: 69.
6. Charney DA, Nadasdy T, Wing-Hong A, Racusen LC. Plasma cell-rich acute renal allograft rejection. Transplantation 1999: 27: 791.
7. Rogers NM, Lawton PD, Jose MD. Plasma cell infiltrates and renal allograft outcomes in indigenous and non-indigenous people of the Northern Territory of Australia. Nephrology 2011: 16: 777.
8. Gupta R, Sharma A, Mahanta PJ, Agarwal SK, Dinda AK. Plasma cell-rich acute rejection of the renal allograft: a distinctive morphologic form of acute rejection? Indian J Nephrol 2012: 22: 184.
9. Desvaux D, Le Gouvello S, Pastural M et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant 2004: 19: 933.
10. Carpio VN, Noronha Ide L, Martins HL et al. Expression patterns of B cells in acute kidney transplant rejection. Exp Clin Transplant 2014: 12: 405.
11. Zarkhin V, Kambham N, Li L et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008: 74: 664.
12. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008: 8: 753.
13. Haas M, Sis B, Racusen LC et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014: 14: 272.
14. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003: 3: 708.
15. Gärtner V, Eigentler TK, Viebahn R. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation 2006: 81: 986.
16. Meehan SM, Domer P, Josephson M et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001: 32: 205.
17. Rizvi SA, Naqvi SA, Hussain Z et al. Living-related pediatric renal transplants: a single-center experience from a developing country. Pediatr Transplant 2002: 6: 101.
18. Lerut E, Kuypers DR, Verbeken E et al. Acute rejection in non-compliant renal allograft recipients: a distinct morphology. Clin Transplant 2007: 21: 344.
19. Sellarés J, de Freitas DG, Mengel M et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012: 12: 388.
20. Trpkov K, Marcussen N, Rayner D, Lam G, Solez K. Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities? Am J Kidney Dis 1997: 30: 449.
21. Liptak P, Kemeny E, Ivanyi B. Primer: histopathology of polyomavirus-associated nephropathy in renal allografts. Nat Clin Pract Nephrol 2006: 2: 631.
22. Mohan S, Palanisamy A, Tsapepas D et al. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 2012: 23: 2061.
23. Torres IB, Salcedo M, Moreso F et al. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection. Clin Transplant 2014: 28: 1148.
24. Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002: 74: 1192.
25. Martin L, Charon-Barra C, Bocrie O et al. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction. Transpl Immunol 2010: 22: 110.
26. Wiebe C, Gibson IW, Blydt-Hansen TD et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012: 12: 1157.
27. Raghavan R, Jeroudi A, Achkar K, Gaber AO, Patel SJ, Abdellatif A. Bortezomib in kidney transplantation. Am J Transplant 2010: 2010: 698594.
28. Blume OR, Yost SE, Kaplan B. Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes. Am J Transplant 2012: 2012: 201754.
29. Sun Q, Cheng Z, Cheng D et al. De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection. Kidney Int 2011: 79: 655.